Stockscreener 앱 받기
16.81
3.64%
0.59
시간 외 거래:
16.52
-0.29
-1.73%
전일 마감가:
$16.22
열려 있는:
$16.19
하루 거래량:
137.13K
Relative Volume:
1.43
시가총액:
$265.46M
수익:
$306.91M
순이익/손실:
$-59.11M
주가수익비율:
-112.07
EPS:
-0.15
순현금흐름:
$6.35M
1주 성능:
+4.83%
1개월 성능:
+45.04%
6개월 성능:
+73.30%
1년 성능:
+22.52%
1일 변동 폭
$15.78
$16.98
1주일 범위
$15.34
$16.98
52주 변동 폭
$7.08
$17.18
Amarin Corp Adr Stock (AMRN) Company Profile
명칭
Amarin Corp Adr
전화
353 1 6699 020
주소
SPACES SOUTH DOCKLANDS, BLOCK C, DUBLIN 2
AMRN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AMRN
Amarin Corp Adr
|
16.81 | 265.46M | 306.91M | -59.11M | 6.35M | -0.15 |
|
LLY
Lilly Eli Co
|
775.90 | 724.64B | 49.00B | 11.11B | -1.27B | 12.29 |
|
JNJ
Johnson Johnson
|
155.92 | 376.43B | 89.33B | 21.81B | 18.57B | 8.99 |
|
NVO
Novo Nordisk Adr
|
69.82 | 352.49B | 43.59B | 15.04B | 10.74B | 3.3766 |
|
ABBV
Abbvie Inc
|
189.99 | 334.73B | 57.37B | 4.20B | 15.39B | 2.35 |
|
NVS
Novartis Ag Adr
|
123.10 | 234.21B | 53.22B | 12.86B | 14.85B | 6.39 |
Amarin Corp Adr Stock (AMRN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-11-20 | 재개 | JP Morgan | Underweight |
| 2023-10-25 | 다운그레이드 | Jefferies | Buy → Hold |
| 2023-01-06 | 업그레이드 | Jefferies | Hold → Buy |
| 2022-05-06 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2022-05-05 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2022-05-05 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2022-05-04 | 다운그레이드 | Northland Capital | Outperform → Market Perform |
| 2021-05-12 | 다운그레이드 | Goldman | Neutral → Sell |
| 2020-09-29 | 재개 | JP Morgan | Neutral |
| 2020-08-26 | 개시 | Piper Sandler | Overweight |
| 2020-05-05 | 개시 | Northland Capital | Outperform |
| 2020-03-31 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-03-31 | 다운그레이드 | Jefferies | Buy → Hold |
| 2020-03-31 | 업그레이드 | Oppenheimer | Underperform → Perform |
| 2020-03-13 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-03-02 | 개시 | Cowen | Outperform |
| 2020-02-18 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-01-06 | 개시 | JP Morgan | Neutral |
| 2019-12-16 | 다운그레이드 | Stifel | Buy → Hold |
| 2019-11-20 | 개시 | Oppenheimer | Underperform |
| 2019-11-18 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2019-11-15 | 재확인 | SVB Leerink | Outperform |
| 2019-10-31 | 개시 | Aegis Capital | Buy |
| 2019-10-15 | 개시 | Goldman | Neutral |
| 2019-08-14 | 개시 | SVB Leerink | Outperform |
| 2019-07-09 | 재확인 | Jefferies | Buy |
| 2019-06-17 | 개시 | ROTH Capital | Buy |
| 2019-03-22 | 개시 | Stifel | Buy |
모두보기
Amarin Corp Adr 주식(AMRN)의 최신 뉴스
Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
KURA Stock Rises More Than 15% This Past Week: Here's Why - Barchart.com
Is GSK PLC Sponsored ADR (GSK) Outperforming Other Medical Stocks This Year? - Yahoo Finance
RCKT Stock Tanks On Patient Death In Danon Disease Study - Barchart.com
Amarin's Q1 Earnings Beat Estimates, Revenues Decline Y/Y - Barchart.com
Amarin to Report First Quarter 2025 Financial Results and Host Conference Call on May 7, 2025 - Barchart.com
Press Release Distribution & PR Platform - ACCESS Newswire
Looking For A Top Momentum Stock? Check Out Amarin Corp ADR (NASDAQ: AMRN) - Stocksregister
Amarin Takes Critical Step to Avoid Nasdaq Delisting with 1-for-20 Share Consolidation - Stock Titan
Amarin announces ADS ratio change to meet Nasdaq requirements - Investing.com
Major Shake-up: Investment Firm Leader Joins Amarin Board to Drive Shareholder Value - Stock Titan
Amarin adds investment expert Michael Torok to Board By Investing.com - Investing.com
Upcoming Stock Splits This Week (April 7 to April 11) – Stay Invested - markets.businessinsider.com
A Look at New Gold Inc (NGD) Shares in the Recent Past Indicates Growth - Sete News
Breakthrough: EPA Treatment Shows Double Impact on Heart Disease When Combined with Popular Diabetes Drug - Stock Titan
Amarin announces board member departure ahead of annual meeting - Investing.com
European Equities Traded in the US as American Depositary Receipts Track Lower in Wednesday Trading - TradingView
Amarin urged to review strategy by major shareholders - Investing.com
Assessing the Risk and Potential of Sempra’s (SRE) Stock - The News Heater
Amarin Corporation plc (NASDAQ:AMRN) Q4 2024 Earnings Call Transcript - Insider Monkey
Amarin Corp PLC (AMRN) Q4 2024 Earnings Call Highlights: Navigating Challenges and Expanding ... - Yahoo Finance
Amarin Plc (AMRN) Q4 2024 Earnings Call Transcript - The Motley Fool
Amarin announce splan to initiate ratio change under ADR program - TipRanks
Amarin Announces Plan to Initiate a Ratio Change Under Its American Depository Receipt (ADR) Program - The Manila Times
Amarin Corp. (AMRN) Announces 1-For-20 ADS Ratio Change to Maintain Nasdaq Listing - StreetInsider.com
Amarin Plans Major ADR Restructuring: What This 1:20 Ratio Change Means for Investors - StockTitan
How Amarin's Latest European Reimbursement Victory Strengthens Its Cardiovascular Market Position - Stock Titan
Will Amarin's Q4 Earnings Mark a Turning Point? Key Date and Details Revealed - Stock Titan
Amarin Corp ADR (AMRN) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - SETE News
European Equities Traded in the US as American Depositary Receipts Tread Water in Wednesday Trading - TradingView
Amarin Corp ADR [AMRN] Stock bought by Insider Berg Aaron for $0.1 million - Knox Daily
Ratios Uncovered: Breaking Down Amarin Corp ADR (AMRN)’s Trailing Twelve Months Metrics - The Dwinnex
Checking in on Indivior Plc (INDV) after recent insiders movement - Knox Daily
Ratios Uncovered: Breaking Down Neuronetics Inc (STIM)’s Trailing Twelve Months Metrics - The Dwinnex
Are Smart Investors Making the Right Decision? Amarin Corp ADR (AMRN) - SETE News
Views of Wall Street’s Leading Experts on SciSparc Ltd - SETE News
Stocks of Talen Energy Corp (TLN) are poised to climb above their peers - SETE News
Scholar Rock Holding Corp (SRRK) requires closer examination - US Post News
Amarin Corp ADR (AMRN) shows promising results - US Post News
Analysts review Amarin Corp ADR’s rating - Knox Daily
ALLY’s latest rating updates from top analysts. - Knox Daily
Ratio Review: Analyzing Caleres Inc (CAL)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Financial Health Report: Tevogen Bio Holdings Inc (TVGN)’s Ratios Tell a Tale - The Dwinnex
Financial Metrics Exploration: Understanding Opendoor Technologies Inc (OPEN) Through Ratios - The Dwinnex
Potential Price Increase for Godaddy Inc (GDDY) After Recent Insider Activity - Knox Daily
Analyzing Ratios: Amarin Corp ADR (AMRN)’s Financial Story Unveiled - The Dwinnex
Establishment Labs Holdings Inc (ESTA) expanding its growth trajectory ahead - SETE News
European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading - MSN
Amarin stock touches 52-week low at $0.45 amid challenges - Investing.com
Italy grants VAZKEPA reimbursement for heart risk - Investing.com
Amarin appoints new chief financial officer - Investing.com
Amarin Corp Adr (AMRN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.53%
자본화:
|
볼륨(24시간):